Has Salman Azhar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $105,688 in general payments to Salman Azhar, MD across 93 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Salman Azhar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Salman Azhar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Salman Azhar, MD

Neurology · Brooklyn, NYNPI 1952460479

Payments from drug & device makers

$105,688in general payments, 2019–2025

Across 93 payments — averaging $1136.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Research & Development, LLC$41K
Medtronic$33K
AstraZeneca$32K
AbbVie$324
SPR Therapeutics, Inc$276

What the payments were for

Consulting fees$4,70014%
Speaking & faculty fees$20,43062%
Travel & lodging$5,43716%
Food & beverage$2,5938%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Research & Development, LLC	6	$40,656
Medtronic	68	$32,560
AstraZeneca	2	$31,872
AbbVie(2 entities)	15	$324
SPR Therapeutics, Inc	2	$276

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LINQ II$298
SPRINT PNS System$276

How this compares

$105,688 in reported general payments places this provider in the 85th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$149,842

Medicare patients

345

Services billed

5,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
PrivigenImmun Glob G(Igg)/Pro/Iga 0-50	14	$270,830
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50	14	$252,893
Gamunex-CImmune Globul G/Gly/Iga Avg 46	12	$88,374
EliquisApixaban	19	$15,177
Memantine Hcl	25	$631
Levetiracetam	15	$376
Rosuvastatin Calcium	21	$367
Duloxetine Hcl	24	$276
Olanzapine	11	$224
Atorvastatin Calcium	27	$190
Gabapentin	29	$170
Donepezil Hcl	19	$144
Sertraline Hcl	12	$55
Topiramate	14	$47

Paid to pharmacies, not to this prescriber.

Other neurology in Brooklyn

Idan SharonBrooklyn$2.1M
Christian GrommesNew York$9.9M
Ilya KisterNew York$9.5M
E DorseyNew York$8.5M
Lauren SchaffNew York$8.2M
Richard HolubAlbany$6.3M
Martin SadowskiNew York$5.4M
Lawrence HonigNew York$4.9M
Laszlo MechtlerAmherst$4.3M
Bennett MyersAmherst$3.8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →